Effects of exercise and dietary interventions on asprosin, leptin, and lipid metabolism in males with abdominal obesity, a randomized controlled trial - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/39548289/
Addressing abdominal obesity requires multifaceted strategies, with physical activity and diet playing a pivotal role. The objective of this study was to assess alterations in body composition, adipokine concentrations, insulin...
In men with abdominal obesity, combining exercise with a high-protein, low-glycemic diet produced greater reductions in body fat, adipokines, insulin resistance, and cholesterol, outperforming exercise alone.
Share
Nutrition and Lifestyle Interventions in Managing Dyslipidemia and Cardiometabolic Risk - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/40077646/
Dyslipidemia, characterized by abnormal blood lipid levels, is a major public health concern due to its association with atherosclerotic cardiovascular disease (ASCVD) and other cardiometabolic disorders. In this context, appropriate...
Dyslipidemia management relies on evidence-based nutrition patterns like Mediterranean, plant-based, and high-fiber diets, enriched with bioactive compounds. Combined with lifestyle interventions and nutrigenomics, these approaches improve lipid profiles and cardiovascular outcomes.
Share
Learnings from Implementation Strategies to Improve Lipid Management - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/39775142/
Implementation studies are heterogenous in their strategies and design. At the clinician level, multidisciplinary team-based care (including multidisciplinary lipid clinics), pharmacist- or nurse-led interventions, decision-support algorithms or protocols, and educational...
This review highlights strategies to optimize lipid management, including team-based care, patient adherence interventions, EHR tools, and telehealth, emphasizing multifaceted approaches and long-term implementation research for sustainable cardiovascular risk reduction.
Share
Post myocardial infarction patients are usually started on high intensity statin Rx. Followup in office will include following lipid panel. Insurance carrier permitting, an injectable lipid lowering medication can be added if LDL is not below 55, but usually insurance only permits addition of injectables if LDL remains above 70 on high intensity...
Share
Expert opinion on the integration of combination therapy into the treatment algorithm for the management of dyslipidaemia: the integration of ezetimibe and bempedoic acid may enhance goal attainment - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/40052330/
The clinically important link between LDL cholesterol (LDL - C) lowering and cardiovascular (CV) risk reduction is well-established and reflected in the 2019 European Society of Cardiology/European Atherosclerosis Society guidelines...
Expert consensus highlights LDL-C goal gaps in practice, recommending upfront combination lipid-lowering therapy, including novel agents like bempedoic acid, for high/very high cardiovascular risk and statin-intolerant patients.
Share